Showing 1 - 5 results of 5 for search 'N. Potter', query time: 0.03s
Refine Results
-
1
-
2
-
3
-
4
-
5
S126: GEMTUZUMAB-BASED INDUCTION CHEMOTHERAPY COMBINED WITH MIDOSTAURIN FOR FLT3 MUTATED AML. RESULTS FROM THE NCRI AML19 “MIDOTARG” PILOT TRIAL by N. Russell, C. Wilhelm-Benartzi, J. Othman, R. Dillon, N. Potter, J. Jovanovic, A. Gilkes, L. M. Batten, J. Canham, E. L. Hinson, P. Kottaridis, J. Cavenagh, C. Arnold, M. Dennis, S. Knapper
Published 2022-06-01
Article